Endocrine Journal · 2009 · 54 citations · 37 references
Life SciencesNeurosciencePharmacologyApoptosisMolecular NeuroscienceSignal TransductionApoptosis PharmacologyApoptosis RegulationApoptotic SignalingNeuronal Cell DeathNeuroprotectionNeuroprotective PharmacologyCaspase-4 ActivationCerebral Ischemia NeuroprotectionIschemic Cell InjuryIschemic Neuronal DeathNeuroprotective AgentsNeuroprotective PeptidesNeuroprotective ResponsesStroke Neuroprotection
Ghrelin is known to promote neuronal defense and survival against ischemic injury by inhibiting apoptotic processes. In the present study, we investigated the role of prostate apoptosis response-4 (Par-4), a proapoptotic gene the expression of which is increased after ischemic injury, in ghrelin-mediated neuroprotection during middle cerebral artery occlusion (MCAO). Both ghrelin and des-acyl ghrelin protected cortical neurons from ischemic injury. Ghrelin receptor specific antagonist abolished the protective effects of ghrelin, whereas those of des-acyl ghrelin were preserved, suggesting the involvement of a receptor that is distinct from GHS-R1a. The expression of Par-4 was increased by MCAO, which was attenuated by ghrelin and des-acyl ghrelin treatments. Both ghrelin and des-acyl ghrelin increased the Bcl-2/Bax ratio, prevented cytochrome c release, and inhibited caspase-3 activation. Our data indicate that des-acyl ghrelin, as well as ghrelin, protect cortical neurons against ischemic injury through the inhibition of Par-4 expression and apoptotic molecules in mitochondrial pathway.
37
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Masayasu Kojima, Hiroshi Hosoda, Yukari Date et al. · Nature · 1999 · 8.5K citations
Elizabeth A. Slee, Mary T. Harte, Ruth M. Kluck et al. · The Journal of Cell Biology · 1999 · 1.9K citations · Full text
Yukari Date, Masayasu Kojima, Hiroshi Hosoda et al. · Endocrinology · 2000 · 1.8K citations